71-Year-Old Male Patient With Therapy-Related AML

Dr Deepak Mannari explores the case study of a patient with treatment related AML following prostate cancer therapy; explaining the management of the condition with Vyxeos Liposomal to induce morphological and cytogenetic remission.

Prescribing Information can be found at the top of this page. Adverse event reporting is available at the bottom of this page.

Topics: AML Landscape Safety Vyxeos Liposomal Data


Adverse events should be reported. Reporting forms and information for the UK can be found at https://yellowcard.mhra.gov.uk/

For Ireland, reporting forms and information can be found at: www.hpra.ie

Adverse events should also be reported to Jazz Pharmaceuticals at AEreporting@jazzpharma.com

UK-VYX-2100018 | May 2021